Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

By sjmartinez • September 6, 2024

Armstrong AW, Riedl E, Brunner PM, Piaserico S, Visser WI, Haustrup N, Konicek BW, Kadziola Z, Nunez M, Brnabic A, Schuster C. Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO). Acta Derm Venereol. 2024 Sep 5;104:adv40556. doi: 10.2340/actadv.v104.40556. PMID: 39235051.

Tags: Dermatology, Publications

Primary Cutaneous Melanoma Microbiome is Associated with Overall Survival and Recurrence

Chan AA, Noguti J, Ramirez NM, Navarrete M, Lee DJ. Primary Cutaneous Melanoma Microbiome is Associated with Overall Survival and Recurrence. J Invest Dermatol. 2025[...]

To Treat or Not to Treat: Two Roads Traveled With Alopecia Areata

Taghizadeh CS, Goh C. To Treat or Not to Treat: Two Roads Traveled With Alopecia Areata. Pediatr Dermatol. 2025 Aug 15. doi: 10.1111/pde.70006. Epub ahead[...]

Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells

Li YR, Li Z, Zhu Y, Li M, Chen Y, Lee D, Ochoa CJ, Singh T, DiBernardo G, Guo W, Li S, Zhou Y, Yu[...]